{"id":"W4416028285","doi":"10.1016/j.bneo.2025.100179","title":"Mezigdomide combined with bortezomib disrupts the cell cycle and elicits superior antitumor effects in multiple myeloma","year":2025,"lang":"en","type":"article","venue":"Blood Neoplasia","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Bortezomib; Multiple myeloma; Proteasome; In vivo; Proteasome inhibitor; Cereblon; Cytotoxic T cell; Pomalidomide; Cell cycle","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001022353,0.0001584358,0.0001587068,0.00005047634,0.0001066185,0.00004100972,0.0001377654,0.00008798949,0.000002545426],"category_scores_gemma":[0.00008941417,0.0001094298,0.00003465644,0.0001580432,0.00009211642,0.000006434002,0.00009342698,0.00009882225,0.0000033484],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00000532115,"about_ca_system_score_gemma":0.00006594925,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000544444,"about_ca_topic_score_gemma":0.0003912616,"domain_scores_codex":[0.9991833,0.00007298365,0.0001587714,0.0002960335,0.00008348399,0.0002054024],"domain_scores_gemma":[0.9995547,0.00004796143,0.00004315128,0.000276261,0.00002745182,0.0000504764],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0006248632,0.0002901451,0.1118645,0.0001264429,0.00007173712,0.00003823566,0.0001132388,0.00002577781,0.8839033,0.0003043078,0.0009502105,0.00168718],"study_design_scores_gemma":[0.00474249,0.0003809903,0.08302753,0.00006167742,0.00003802886,0.00001738847,0.00007092341,0.0001860019,0.9087618,0.00003267298,0.002518484,0.0001620087],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971578,0.0007759627,0.00007658832,0.0003342877,0.00008432961,0.0005580456,0.000006347108,0.00001567318,0.0009909384],"genre_scores_gemma":[0.9983444,0.00007243309,0.0002921663,0.0003999817,0.00003844738,0.00008090123,0.00002834116,0.00001470337,0.0007286452],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02883702,"threshold_uncertainty_score":0.4462417,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.002477814032634891,"score_gpt":0.1963974673481172,"score_spread":0.1939196533154824,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}